Progestogens for Prevention of Preterm Birth
Clinically Significant Outcomes of Interest in the Comparative Effectiveness Review (2 of 2)
Maternal and child adverse effects examined in the effectiveness review included complications during pregnancy (allergic reactions and gestational diabetes), the mode of birth and complications (including unanticipated maternal harms), and postpartum and neonatal complications (such as infection and sepsis). Examined longer term outcomes included reproductive and neurodevelopmental adverse effects.
- Likis FE, Andrews JC, Woodworth AL, et al. Effectiveness of Progestogens for Prevention of Preterm Birth. Comparative Effectiveness Review No. 74 (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2012. AHRQ Publication No. 12-EHC105-EF. Available at www.effectivehealthcare.ahrq.gov/pretermbirth.cfm.
Your slide tray is being processed.